ANALYSIS: With an Obermatt 360° View of 82 (better than 82% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Bristol-Myers Squibb are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Bristol-Myers Squibb. The consolidated Value Rank has an attractive rank of 91, which means that the share price of Bristol-Myers Squibb is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 91% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 73. But the company’s financing is risky with a Safety rank of 46. This means 54% of comparable companies have a safer financing structure than Bristol-Myers Squibb. ...read more